ASPEN AEROGELS INC (ASPN)
US04523Y1055 - Common Stock
Overall ASPN gets a fundamental rating of 4 out of 10. We evaluated ASPN against 85 industry peers in the Chemicals industry. ASPN scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. ASPN shows excellent growth, but is valued quite expensive already.
1. Profitability
1.1 Basic Checks
In the past year ASPN was profitable.
In the past year ASPN had a positive cash flow from operations.
ASPN had negative earnings in each of the past 5 years.
ASPN had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of 0.19%, ASPN is doing worse than 62.65% of the companies in the same industry.
The Return On Equity of ASPN (0.29%) is worse than 62.65% of its industry peers.
The Return On Invested Capital of ASPN (5.11%) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.19% | ||
| ROE | 0.29% | ||
| ROIC | 5.11% |
ROA(3y)-13.21%
ROA(5y)-15.23%
ROE(3y)-18.92%
ROE(5y)-22.72%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Profit Margin, with a value of 0.36%, ASPN is doing worse than 62.65% of the companies in the same industry.
With a decent Operating Margin value of 10.61%, ASPN is doing good in the industry, outperforming 60.24% of the companies in the same industry.
The Gross Margin of ASPN (39.96%) is better than 80.72% of its industry peers.
ASPN's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 10.61% | ||
| PM (TTM) | 0.36% | ||
| GM | 39.96% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y17.88%
GM growth 5Y14.41%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ASPN is destroying value.
The number of shares outstanding for ASPN has been increased compared to 1 year ago.
Compared to 5 years ago, ASPN has more shares outstanding
Compared to 1 year ago, ASPN has a worse debt to assets ratio.
2.2 Solvency
ASPN has an Altman-Z score of 2.05. This is not the best score and indicates that ASPN is in the grey zone with still only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.05, ASPN is in line with its industry, outperforming 59.04% of the companies in the same industry.
ASPN has a Debt/Equity ratio of 0.29. This is a healthy value indicating a solid balance between debt and equity.
ASPN has a Debt to Equity ratio of 0.29. This is in the better half of the industry: ASPN outperforms 73.49% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.29 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 2.05 |
ROIC/WACC0.6
WACC8.52%
2.3 Liquidity
A Current Ratio of 2.93 indicates that ASPN has no problem at all paying its short term obligations.
ASPN has a Current ratio of 2.93. This is amongst the best in the industry. ASPN outperforms 81.93% of its industry peers.
A Quick Ratio of 2.48 indicates that ASPN has no problem at all paying its short term obligations.
The Quick ratio of ASPN (2.48) is better than 85.54% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.93 | ||
| Quick Ratio | 2.48 |
3. Growth
3.1 Past
ASPN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 143.53%, which is quite impressive.
ASPN shows a strong growth in Revenue. In the last year, the Revenue has grown by 93.27%.
Measured over the past years, ASPN shows a quite strong growth in Revenue. The Revenue has been growing by 17.99% on average per year.
EPS 1Y (TTM)143.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%200%
Revenue 1Y (TTM)93.27%
Revenue growth 3Y33.51%
Revenue growth 5Y17.99%
Sales Q2Q%93.14%
3.2 Future
ASPN is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 35.39% yearly.
ASPN is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 37.03% yearly.
EPS Next Y116.66%
EPS Next 2Y65.26%
EPS Next 3Y49.32%
EPS Next 5Y35.39%
Revenue Next Year91.37%
Revenue Next 2Y45.89%
Revenue Next 3Y41.34%
Revenue Next 5Y37.03%
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 33.70, the valuation of ASPN can be described as expensive.
63.86% of the companies in the same industry are cheaper than ASPN, based on the Price/Earnings ratio.
ASPN is valuated rather expensively when we compare the Price/Earnings ratio to 27.28, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 25.85, the valuation of ASPN can be described as expensive.
ASPN's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. ASPN is more expensive than 65.06% of the companies in the same industry.
ASPN is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 23.53, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 33.7 | ||
| Fwd PE | 25.85 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, ASPN is valued a bit more expensive than 71.08% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 16.57 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as ASPN's earnings are expected to grow with 49.32% in the coming years.
PEG (NY)0.29
PEG (5Y)N/A
EPS Next 2Y65.26%
EPS Next 3Y49.32%
5. Dividend
5.1 Amount
No dividends for ASPN!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
ASPEN AEROGELS INC
NYSE:ASPN (1/14/2025, 8:24:20 PM)
After market: 12.51 +0.04 (+0.32%)12.47
-0.26 (-2.04%)
Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)
Earnings (Next)
Inst Owners80.34%
Inst Owner Change0%
Ins Owners1.55%
Ins Owner Change-0.23%
Market Cap1.02B
Analysts82.35
Price Target30.6 (145.39%)
Short Float %12.17%
Short Ratio4.54
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)335.99%
Min EPS beat(2)328.03%
Max EPS beat(2)343.94%
EPS beat(4)4
Avg EPS beat(4)211.59%
Min EPS beat(4)82.87%
Max EPS beat(4)343.94%
EPS beat(8)8
Avg EPS beat(8)124.1%
EPS beat(12)8
Avg EPS beat(12)71.49%
EPS beat(16)9
Avg EPS beat(16)48.44%
Revenue beat(2)2
Avg Revenue beat(2)9.53%
Min Revenue beat(2)5.19%
Max Revenue beat(2)13.88%
Revenue beat(4)4
Avg Revenue beat(4)11.18%
Min Revenue beat(4)2.11%
Max Revenue beat(4)23.52%
Revenue beat(8)6
Avg Revenue beat(8)7.13%
Revenue beat(12)8
Avg Revenue beat(12)4.18%
Revenue beat(16)11
Avg Revenue beat(16)5.02%
PT rev (1m)0%
PT rev (3m)-8.33%
EPS NQ rev (1m)0%
EPS NQ rev (3m)1374.82%
EPS NY rev (1m)0%
EPS NY rev (3m)-48.94%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)23.19%
Revenue NY rev (1m)0.06%
Revenue NY rev (3m)11.85%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 33.7 | ||
| Fwd PE | 25.85 | ||
| P/S | 2.47 | ||
| P/FCF | N/A | ||
| P/OCF | 144.45 | ||
| P/B | 2.02 | ||
| P/tB | 2.02 | ||
| EV/EBITDA | 16.57 |
EPS(TTM)0.37
EY2.97%
EPS(NY)0.48
Fwd EY3.87%
FCF(TTM)-1.12
FCFYN/A
OCF(TTM)0.09
OCFY0.69%
SpS5.04
BVpS6.19
TBVpS6.19
PEG (NY)0.29
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.19% | ||
| ROE | 0.29% | ||
| ROCE | 6.47% | ||
| ROIC | 5.11% | ||
| ROICexc | 6.14% | ||
| ROICexgc | 6.14% | ||
| OM | 10.61% | ||
| PM (TTM) | 0.36% | ||
| GM | 39.96% | ||
| FCFM | N/A |
ROA(3y)-13.21%
ROA(5y)-15.23%
ROE(3y)-18.92%
ROE(5y)-22.72%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y17.88%
GM growth 5Y14.41%
F-Score6
Asset Turnover0.53
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.29 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 2.24 | ||
| Cap/Depr | 458.62% | ||
| Cap/Sales | 23.99% | ||
| Interest Coverage | 18.85 | ||
| Cash Conversion | 10.8% | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.93 | ||
| Quick Ratio | 2.48 | ||
| Altman-Z | 2.05 |
F-Score6
WACC8.52%
ROIC/WACC0.6
Cap/Depr(3y)1073.88%
Cap/Depr(5y)655.17%
Cap/Sales(3y)61.16%
Cap/Sales(5y)37.68%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)143.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%200%
EPS Next Y116.66%
EPS Next 2Y65.26%
EPS Next 3Y49.32%
EPS Next 5Y35.39%
Revenue 1Y (TTM)93.27%
Revenue growth 3Y33.51%
Revenue growth 5Y17.99%
Sales Q2Q%93.14%
Revenue Next Year91.37%
Revenue Next 2Y45.89%
Revenue Next 3Y41.34%
Revenue Next 5Y37.03%
EBIT growth 1Y172.88%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year256.53%
EBIT Next 3Y66.63%
EBIT Next 5Y47.65%
FCF growth 1Y55.96%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y108.6%
OCF growth 3YN/A
OCF growth 5YN/A